Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announces the completion of its acquisition of Clario Holdings, Inc., a leading provider of endpoint data solutions for clinical trials, for $8.875 billion in cash, plus potential additional earnout and other payments, largely dependent on performance. With the transaction complete, the Clario business will become part of Thermo Fisher’s Laboratory Products and Biopharma Services segment. Clario’s industry-leading solutions are highly complementary to Thermo Fisher’s clinical research offerings, enabling customers to gain critical insights from patient data to improve decision-making, accelerate innovation and drive greater productivity.
Read the full article: Thermo Fisher Scientific Completes Acquisition of Clario Holdings, Inc. //
Source: https://www.businesswire.com/news/home/20260324226576/en/Thermo-Fisher-Scientific-Completes-Acquisition-of-Clario-Holdings-Inc.